TY - JOUR AU - Brooks, S. E. AU - Zhan, M. AU - Cote, T. AU - Baquet, C. R. PY - 2004 DA - 2004// TI - Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999 JO - Gynecol Oncol VL - 93 UR - https://doi.org/10.1016/j.ygyno.2003.12.029 DO - 10.1016/j.ygyno.2003.12.029 ID - Brooks2004 ER - TY - JOUR AU - Cimbaluk, D. AU - Rotmensch, J. AU - Scudiere, J. AU - Gown, A. AU - Bitterman, P. PY - 2007 DA - 2007// TI - Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets JO - Gynecol Oncol VL - 105 UR - https://doi.org/10.1016/j.ygyno.2006.11.001 DO - 10.1016/j.ygyno.2006.11.001 ID - Cimbaluk2007 ER - TY - JOUR AU - Giuntoli, R. L. AU - Metzinger, D. S. AU - DiMarco, C. S. AU - Cha, S. S. AU - Sloan, J. A. AU - Keeney, G. L. PY - 2003 DA - 2003// TI - Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy JO - Gynecol Oncol VL - 89 UR - https://doi.org/10.1016/S0090-8258(03)00137-9 DO - 10.1016/S0090-8258(03)00137-9 ID - Giuntoli2003 ER - TY - JOUR AU - Arend, R. AU - Doneza, J. A. AU - Wright, J. D. PY - 2011 DA - 2011// TI - Uterine carcinosarcoma JO - Curr Opin Oncol VL - 23 ID - Arend2011 ER - TY - JOUR AU - Rayson, D. AU - Adjei, A. A. AU - Suman, V. J. AU - Wold, L. E. AU - Ingle, J. N. PY - 1999 DA - 1999// TI - Metaplastic breast cancer: prognosis and response to systemic therapy JO - Ann Oncol VL - 10 UR - https://doi.org/10.1023/A:1008329910362 DO - 10.1023/A:1008329910362 ID - Rayson1999 ER - TY - JOUR AU - Luini, A. AU - Aguilar, M. AU - Gatti, G. AU - Fasani, R. AU - Botteri, E. AU - Brito, J. A. PY - 2007 DA - 2007// TI - Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature JO - Breast Cancer Res Treat VL - 101 UR - https://doi.org/10.1007/s10549-006-9301-1 DO - 10.1007/s10549-006-9301-1 ID - Luini2007 ER - TY - JOUR AU - Homesley, H. D. AU - Filiaci, V. AU - Markman, M. AU - Bitterman, P. AU - Eaton, L. AU - Kilgore, L. C. PY - 2007 DA - 2007// TI - Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group study JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.06.4907 DO - 10.1200/JCO.2006.06.4907 ID - Homesley2007 ER - TY - JOUR AU - Emoto, M. AU - Charnock-Jones, D. S. AU - Licence, D. R. AU - Ishiguro, M. AU - Kawai, M. AU - Yanaihara, A. PY - 2004 DA - 2004// TI - Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma JO - Gynecol Oncol VL - 95 UR - https://doi.org/10.1016/j.ygyno.2004.08.042 DO - 10.1016/j.ygyno.2004.08.042 ID - Emoto2004 ER - TY - JOUR AU - Arita, S. AU - Kikkawa, F. AU - Kajiyama, H. AU - Shibata, K. AU - Kawai, M. AU - Mizuno, K. PY - 2005 DA - 2005// TI - Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma JO - Int J Gynecol Cancer VL - 15 UR - https://doi.org/10.1111/j.1525-1438.2005.15225.x DO - 10.1111/j.1525-1438.2005.15225.x ID - Arita2005 ER - TY - JOUR AU - Etoh, T. AU - Nakai, H. PY - 2014 DA - 2014// TI - Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma JO - J Obstet Gynaecol Res VL - 40 UR - https://doi.org/10.1111/jog.12251 DO - 10.1111/jog.12251 ID - Etoh2014 ER - TY - JOUR AU - Ratner, E. S. AU - Tuck, D. AU - Richter, C. AU - Nallur, S. AU - Patel, R. M. AU - Schultz, V. PY - 2010 DA - 2010// TI - MicroRNA signatures differentiate uterine cancer tumor subtypes JO - Gynecol Oncol VL - 118 UR - https://doi.org/10.1016/j.ygyno.2010.05.010 DO - 10.1016/j.ygyno.2010.05.010 ID - Ratner2010 ER - TY - JOUR AU - Devor, E. J. AU - Mik, J. N. AU - Ramachandran, S. AU - Goodheart, M. J. AU - Leslie, K. K. PY - 2012 DA - 2012// TI - Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma JO - Exp Ther Med VL - 3 ID - Devor2012 ER - TY - JOUR AU - Hua, Z. AU - Lv, Q. AU - Ye, W. AU - Wong, C. K. A. AU - Cai, G. AU - Gu, D. PY - 2006 DA - 2006// TI - miRNA-directed regulation of VEGF and other angiogenic under hypoxia JO - PLoS One VL - 1 UR - https://doi.org/10.1371/journal.pone.0000116 DO - 10.1371/journal.pone.0000116 ID - Hua2006 ER - TY - JOUR AU - Lei, Z. AU - Li, B. AU - Yang, Z. AU - Fang, H. AU - Zhang, G. M. AU - Feng, Z. H. PY - 2009 DA - 2009// TI - Regulation of HIF-1α and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0007629 DO - 10.1371/journal.pone.0007629 ID - Lei2009 ER - TY - JOUR AU - Penel, N. AU - Adenis, A. AU - Bocci, G. PY - 2012 DA - 2012// TI - Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going? JO - Crit Rev Oncol Hematol VL - 82 UR - https://doi.org/10.1016/j.critrevonc.2011.04.009 DO - 10.1016/j.critrevonc.2011.04.009 ID - Penel2012 ER - TY - JOUR AU - Kerbel, R. S. AU - Kamen, B. A. PY - 2004 DA - 2004// TI - The anti-angiogenic basis of metronomic chemotherapy JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1369 DO - 10.1038/nrc1369 ID - Kerbel2004 ER - TY - JOUR AU - Emmenegger, U. AU - Francia, G. AU - Shaked, Y. AU - Kerbel, R. S. PY - 2010 DA - 2010// TI - Metronomic chemotherapy: principles and lessons learned from applications in the treatment of metastatic prostate cancer JO - Recent Results Cancer Res. VL - 180 UR - https://doi.org/10.1007/978-3-540-78281-0_10 DO - 10.1007/978-3-540-78281-0_10 ID - Emmenegger2010 ER - TY - JOUR AU - Lien, K. AU - Georgsdottir, S. AU - Sivanathan, L. AU - Chan, K. AU - Emmenegger, U. PY - 2013 DA - 2013// TI - Low-dose metronomic chemotherapy: a systematic literature analysis JO - Eur J Cancer VL - 49 UR - https://doi.org/10.1016/j.ejca.2013.06.038 DO - 10.1016/j.ejca.2013.06.038 ID - Lien2013 ER - TY - JOUR AU - Näyhä, V. AU - Stenbäck, F. PY - 2008 DA - 2008// TI - Angiogenesis and expression of angiogenic agents in uterine and ovarian carcinosarcomas JO - APMIS VL - 116 UR - https://doi.org/10.1111/j.1600-0463.2008.00757.x DO - 10.1111/j.1600-0463.2008.00757.x ID - Näyhä2008 ER - TY - JOUR AU - Naganuma, Y. AU - Choijamts, B. AU - Shirota, K. AU - Nakajima, K. AU - Ogata, S. AU - Miyamoto, S. PY - 2011 DA - 2011// TI - Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts JO - Cancer Sci VL - 102 UR - https://doi.org/10.1111/j.1349-7006.2011.01998.x DO - 10.1111/j.1349-7006.2011.01998.x ID - Naganuma2011 ER - TY - JOUR AU - MacKay, H. J. AU - Buckanovich, R. J. AU - Hirte, H. AU - Correa, R. AU - Hoskins, P. AU - Biagi, J. PY - 2012 DA - 2012// TI - A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma: a trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia JO - Gynecol Oncol VL - 125 UR - https://doi.org/10.1016/j.ygyno.2011.11.042 DO - 10.1016/j.ygyno.2011.11.042 ID - MacKay2012 ER - TY - JOUR AU - Campos, S. M. AU - Brady, W. E. AU - Moxley, K. M. AU - O’Cearbhaill, R. E. AU - Lee, P. S. AU - DiSilvestro, P. A. PY - 2014 DA - 2014// TI - A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a Gynecologic Oncology Group study JO - Gynecol Oncol VL - 133 UR - https://doi.org/10.1016/j.ygyno.2014.02.036 DO - 10.1016/j.ygyno.2014.02.036 ID - Campos2014 ER - TY - JOUR AU - McMeekin, D. S. AU - Sill, M. W. AU - Darcy, K. M. AU - Abulafia, O. AU - Hanjani, P. AU - Pearl, M. L. PY - 2012 DA - 2012// TI - A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study JO - Gynecol Oncol VL - 127 UR - https://doi.org/10.1016/j.ygyno.2012.07.095 DO - 10.1016/j.ygyno.2012.07.095 ID - McMeekin2012 ER - TY - JOUR AU - Saglam, O. AU - Husain, S. AU - Toruner, G. PY - 2013 DA - 2013// TI - AKT, EGFR, C-ErbB-2, and C-Kit expression in uterine carcinosarcoma JO - Int J Gynecol Pathol VL - 32 UR - https://doi.org/10.1097/PGP.0b013e31827fedef DO - 10.1097/PGP.0b013e31827fedef ID - Saglam2013 ER -